Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2026	Dec. 31, 2025
Current Assets
Cash and cash equivalents	$ 4,545	$ 3,705
Accounts receivable	120,781	19,299
Other receivable	16,059	14,889
Prepaid expense	38,710	18,757
Due from related party	19,801	8,901
Deferred share issuance cost	254,750	254,750
Total Current Assets	454,646	320,301
Other Assets
Property and Equipment, net	41,724	17,160
Total Assets	496,370	337,461
Current Liabilities
Accounts payable and accrued liabilities	160,412	109,281
Due to related parties	15,338	11,682
Stock payable	169,997	688,934
Total Current Liabilities	345,747	809,897
Loan payable	40,692	0
Total Liabilities	386,439	809,897
STOCKHOLDERS' EQUITY (DEFICIT)
Common Stock: $0.001 par value, 75,000,000 shares authorized, 71,783,325 shares and 61,254,427 shares issued and outstanding, respectively	71,783	61,254
Additional paid-in capital	47,871,921	46,928,116
Accumulated deficit	(40,815,538)	(37,619,073)
Accumulated other comprehensive income	2,022	2,379
Less: Deferred compensation (including $23,795 and $34,890 of deferred compensation to related party, respectively)	(6,375,609)	(9,857,820)
Less: Treasury Stock	(600,000)	0
Total equity (deficit) attributed to Transuite.Org. Inc.	154,579	(485,144)
Non-controlling interest	(44,648)	12,708
Total Stockholders' Equity (Deficit)	109,931	(472,436)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 496,370	$ 337,461